phoxilium 1,2 mmol/1 phosphate solution for hemodialysis/hemofiltration
gambro lundia ab - 1,2 mmol/1 phosphate solution for hemodialysis/hemofiltration
biphozyl solution for haemodialysis/haemofiltration
gambro lundia ab, - solution for haemodialysis/haemofiltration
prismasol potassium 4 mmol/1 solution for haemodialysis ( haemofiltration )
gambro lundia ab - 4 mmol/1 solution for haemodialysis ( haemofiltration )
prismasol potassium 2 mmol/1 solution for haemodialysis ( haemofiltration )
gambro lundia ab - 2 mmol/1 solution for haemodialysis ( haemofiltration )
multilac potassium - free solution for haemodialysis/haemofiltration
fresenius medical care deutschland gmbh, - potassium - free solution for haemodialysis/haemofiltration
multilac 2 mmol/1 potassium solution for haemodialysis/haemofiltration
fresenius medical care deutschland gmbh, - 2 mmol/1 potassium solution for haemodialysis/haemofiltration
multi bic 2 mmol/i potassium solution for haemodialysis/haemofiltration
2 mmol/i potassium solution for haemodialysis/haemofiltration
multi bic potassium-free solution for haemodialysis/haemofiltration
potassium-free solution for haemodialysis/haemofiltration
coagadex
bpl bioproducts laboratory gmbh - Човешкия фактор за съсирването на х - Фактор x недостатъчност - vitamin k and other hemostatics, antihemorrhagics, coagulation factor x - coagadex е показан за лечение и профилактика на епизоди на кървене и за периоперативно лечение при пациенти с дефицит на наследствен фактор Х. coagadex се посочва във всички възрастови групи.
revolade
novartis europharm limited - eltrombopag - Пурпура, Тромбоцитопения, Идиопатична - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 и 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 и 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.